Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia
Clinical trial NCT00838240 · UNKNOWN
Trial details
- NCT number
- NCT00838240
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2012-12-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.